Skip to content

Eikon Therapeutics, Inc.

EIKN Nasdaq SEC CIK 1861123

Follow Eikon Therapeutics Weekly email: filings, results, news

News

1 story filed under Eikon Therapeutics

Eikon Therapeutics, Inc. (EIKN) Discusses Advances in PARP1 Biology and Next-Generation PARP Inhibitors in Oncology Transcript

Markets 33 d ago

Profile

Headquarters: MILLBRAE, CA, United States
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Peers

Where this page comes from

Profile · SEC EDGAR

News · 1 story clustered from the RSS aggregator